Fear Associated with COVID-19 in Patients with Neovascular Age-Related Macular Degeneration

Jean-Philippe Rozon,1,2 Mélanie Hébert,2 Serge Bourgault,2 Mathieu Caissie,2 Laurence Letartre,2 Eric Tourville,2 Ali Dirani2 1Faculty of Medicine, Université Laval, Québec, QC, Canada; 2Department of Ophthalmology, Centre Universitaire d’Ophtalm...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Rozon JP, Hébert M, Bourgault S, Caissie M, Letartre L, Tourville E, Dirani A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	vision loss fear fear assessment fear of covid-19 scale anti-vegf Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/4a244f0477874242be4bd7f03fbc1ea4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:4a244f0477874242be4bd7f03fbc1ea4
record_format	dspace
spelling	oai:doaj.org-article:4a244f0477874242be4bd7f03fbc1ea42021-12-02T14:11:52ZFear Associated with COVID-19 in Patients with Neovascular Age-Related Macular Degeneration1177-5483https://doaj.org/article/4a244f0477874242be4bd7f03fbc1ea42021-03-01T00:00:00Zhttps://www.dovepress.com/fear-associated-with-covid-19-in-patients-with-neovascular-age-related-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Jean-Philippe Rozon,1,2 Mélanie Hébert,2 Serge Bourgault,2 Mathieu Caissie,2 Laurence Letartre,2 Eric Tourville,2 Ali Dirani2 1Faculty of Medicine, Université Laval, Québec, QC, Canada; 2Department of Ophthalmology, Centre Universitaire d’Ophtalmologie, CHU de Québec – Université Laval, Québec, QC, CanadaCorrespondence: Ali DiraniDepartment of Ophthalmology, Hôpital du Saint-Sacrement, 1050 Ste-Foy Street, Quebec City, QC G1S 4L8, CanadaTel +1 418 525-4444Fax +1 418 682-7557Email drdirani@gmail.comPurpose: Since the beginning of the COVID-19 pandemic, news related to the pandemic has created a feeling of fear, particularly among high-risk groups including elderly patients. This study aimed to assess the fear associated with COVID-19 and to evaluate the fear of vision decrease related to the delay of treatment in neovascular age-related macular degeneration patients (nAMD) during the pandemic.Patients and Methods: This is a prospective cross-sectional study of 160 actively treated patients with nAMD enrolled between September and November 2020 at a tertiary hospital in Québec, Canada. For each participant, demographic and clinical data were collected. The anxiety was rated in a questionnaire composed of two sections: the Fear of COVID-19 Scale (FCV-19S) and eight additional questions to assess ophthalmology-related COVID-19 statements.Results: The mean ± standard deviation level of FCV-19S was 17.05± 4.38. In the multivariable analysis, it was significantly higher in women (p< 0.001) and lower in patients with a high school education vs elementary school (p=0.009). In the ophthalmology-related statements, 16% feared vision loss because of difficulties in maintaining regular follow-ups during the pandemic. The female gender was significantly associated with a higher tendency to postpone their appointment (p=0.03). No association was found between the patients’ underlying disease characteristics and higher fear of vision loss.Conclusion: Despite the massive impact of the pandemic, anxiety related to COVID-19 and delaying ophthalmology treatments remained relatively low in nAMD patients. Greater explanations to address this fear may reduce anxiety level, especially among female patients and those with an elementary school education.Keywords: vision loss fear, fear assessment, Fear of COVID-19 Scale, anti-VEGFRozon JPHébert MBourgault SCaissie MLetartre LTourville EDirani ADove Medical Pressarticlevision loss fearfear assessmentfear of covid-19 scaleanti-vegfOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 15, Pp 1153-1161 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	vision loss fear fear assessment fear of covid-19 scale anti-vegf Ophthalmology RE1-994
spellingShingle	vision loss fear fear assessment fear of covid-19 scale anti-vegf Ophthalmology RE1-994 Rozon JP Hébert M Bourgault S Caissie M Letartre L Tourville E Dirani A Fear Associated with COVID-19 in Patients with Neovascular Age-Related Macular Degeneration
description	Jean-Philippe Rozon,1,2 Mélanie Hébert,2 Serge Bourgault,2 Mathieu Caissie,2 Laurence Letartre,2 Eric Tourville,2 Ali Dirani2 1Faculty of Medicine, Université Laval, Québec, QC, Canada; 2Department of Ophthalmology, Centre Universitaire d’Ophtalmologie, CHU de Québec – Université Laval, Québec, QC, CanadaCorrespondence: Ali DiraniDepartment of Ophthalmology, Hôpital du Saint-Sacrement, 1050 Ste-Foy Street, Quebec City, QC G1S 4L8, CanadaTel +1 418 525-4444Fax +1 418 682-7557Email drdirani@gmail.comPurpose: Since the beginning of the COVID-19 pandemic, news related to the pandemic has created a feeling of fear, particularly among high-risk groups including elderly patients. This study aimed to assess the fear associated with COVID-19 and to evaluate the fear of vision decrease related to the delay of treatment in neovascular age-related macular degeneration patients (nAMD) during the pandemic.Patients and Methods: This is a prospective cross-sectional study of 160 actively treated patients with nAMD enrolled between September and November 2020 at a tertiary hospital in Québec, Canada. For each participant, demographic and clinical data were collected. The anxiety was rated in a questionnaire composed of two sections: the Fear of COVID-19 Scale (FCV-19S) and eight additional questions to assess ophthalmology-related COVID-19 statements.Results: The mean ± standard deviation level of FCV-19S was 17.05± 4.38. In the multivariable analysis, it was significantly higher in women (p< 0.001) and lower in patients with a high school education vs elementary school (p=0.009). In the ophthalmology-related statements, 16% feared vision loss because of difficulties in maintaining regular follow-ups during the pandemic. The female gender was significantly associated with a higher tendency to postpone their appointment (p=0.03). No association was found between the patients’ underlying disease characteristics and higher fear of vision loss.Conclusion: Despite the massive impact of the pandemic, anxiety related to COVID-19 and delaying ophthalmology treatments remained relatively low in nAMD patients. Greater explanations to address this fear may reduce anxiety level, especially among female patients and those with an elementary school education.Keywords: vision loss fear, fear assessment, Fear of COVID-19 Scale, anti-VEGF
format	article
author	Rozon JP Hébert M Bourgault S Caissie M Letartre L Tourville E Dirani A
author_facet	Rozon JP Hébert M Bourgault S Caissie M Letartre L Tourville E Dirani A
author_sort	Rozon JP
title	Fear Associated with COVID-19 in Patients with Neovascular Age-Related Macular Degeneration
title_short	Fear Associated with COVID-19 in Patients with Neovascular Age-Related Macular Degeneration
title_full	Fear Associated with COVID-19 in Patients with Neovascular Age-Related Macular Degeneration
title_fullStr	Fear Associated with COVID-19 in Patients with Neovascular Age-Related Macular Degeneration
title_full_unstemmed	Fear Associated with COVID-19 in Patients with Neovascular Age-Related Macular Degeneration
title_sort	fear associated with covid-19 in patients with neovascular age-related macular degeneration
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/4a244f0477874242be4bd7f03fbc1ea4
work_keys_str_mv	AT rozonjp fearassociatedwithcovid19inpatientswithneovascularagerelatedmaculardegeneration AT hebertm fearassociatedwithcovid19inpatientswithneovascularagerelatedmaculardegeneration AT bourgaults fearassociatedwithcovid19inpatientswithneovascularagerelatedmaculardegeneration AT caissiem fearassociatedwithcovid19inpatientswithneovascularagerelatedmaculardegeneration AT letartrel fearassociatedwithcovid19inpatientswithneovascularagerelatedmaculardegeneration AT tourvillee fearassociatedwithcovid19inpatientswithneovascularagerelatedmaculardegeneration AT dirania fearassociatedwithcovid19inpatientswithneovascularagerelatedmaculardegeneration
_version_	1718391839084511232

Fear Associated with COVID-19 in Patients with Neovascular Age-Related Macular Degeneration

Ejemplares similares